Loading...
Market
Will McKinsey's settlement with DOJ impact its government contracts in 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Government contract announcements and official press releases
Story
McKinsey Agrees to $650 Million Settlement with DOJ Over Opioid Consulting and Deferred-Prosecution Agreement
Dec 17, 2024, 01:32 PM
Consulting firm McKinsey & Company has agreed to pay $650 million to resolve a Department of Justice (DOJ) investigation regarding its role in advising Purdue Pharma on increasing OxyContin sales. This settlement comes as part of a deferred-prosecution agreement, allowing McKinsey to avoid criminal charges related to its consulting work that contributed to the opioid epidemic. Critics have expressed concern over the leniency of the settlement, highlighting the firm's significant financial gains from its opioid-related consulting, which coincided with a rise in overdose deaths. The DOJ's decision has sparked debate about the accountability of corporations involved in the opioid crisis, particularly in light of McKinsey's past actions and its ongoing relationship with government entities.
View original story
Similar markets
Significant reduction in consulting operations • 25%
Moderate reduction in consulting operations • 25%
No significant change in consulting operations • 25%
Expansion of consulting operations • 25%
Settlement finalized with over $500 million • 25%
Settlement finalized with exactly $500 million • 25%
Settlement finalized with less than $500 million • 25%
No settlement finalized by end of 2024 • 25%
No wrongdoing found • 25%
Minor violations found • 25%
Major violations found • 25%
Investigation inconclusive • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Significant decline in business operations • 25%
Minor impact on business operations • 25%
No impact on business operations • 25%
Improvement in business operations • 25%
Formal investigation launched • 25%
Contracts reviewed • 25%
No action taken • 25%
New regulations proposed • 25%